Health Platform 160 HEALTH Surges Over 3% on Strong Hospital Partnership Growth

Stock News
06/03

160 HEALTH (SEHK: 02656) shares are trading higher, gaining more than 3% during the session. At the time of writing, the stock is up 2.5% to HK$13.94, with a trading volume of HK$122 million.

Key Developments Driving the Move

The company recently announced significant progress in its "160AI Hospital" operational partnership model from January 2025 through April 30, 2026. The total number of public medical institutions that have entered into operational cooperation with the group has now reached 120.

Within this total, 66 are top-tier Grade III, Class A hospitals, accounting for approximately 55% of the partnerships. The combined number of Grade III and above hospitals stands at 97, representing about 80.8% of the total cooperative institutions.

Significance of the Partnerships

This structure of partnered medical institutions demonstrates that the "160AI Hospital" operational model has gained strong recognition within China's high-end medical system. It has achieved deep penetration and scaled implementation among top-tier hospitals, continuously enhancing the company's brand influence and industry competitiveness.

Operational Service Performance

From January to April 2026, the online operational services provided by the group to its partner hospitals have shown significant effectiveness. These services have successfully helped hospitals expand their service offerings and improve operational efficiency.

As an example, the group provided online operational services for a leading Grade III, Class A hospital in Eastern China. The company charges a service commission of 10% of the Gross Merchandise Volume (GMV) generated. During the operational period, the group successfully assisted this hospital in achieving a breakthrough in online, non-insurance, out-of-pocket payment projects. The GMV for these services demonstrated a remarkable month-on-month compound growth rate of 155.7%.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10